DUBLIN--(BUSINESS WIRE)--The new research portal will provide visitors with unparalleled access to company research on Bristol-Myers Squibb, alongside comprehensive market research on their position within the global pharmaceutical industry.
Bristol-Myers Squibb develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years.
They are a featured company in the Immunotherapy Drugs Market report. The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.
Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, the high cost of immunotherapy treatment, and high attrition rate in the product development cycle are the major factors hindering the growth of the immunotherapy drugs market. However, rising opportunities in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy drugs market.
“Bristol-Myers Squibb is a leading player within the immunotherapy market and the new portal provides easy access to information on their performance as a company and their impact on the overall pharmaceutical industry,” says Ross Glover, CEO of Research and Markets.
For more information visit: http://www.researchandmarkets.com/companies/bristol-myers-squibb?cid=dtqpc3
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.